Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Gilead CAR-T cancer therapy capacity to quadruple by 2026
Reuters
Fri, 03/15/24 - 10:57 am
Gilead Sciences
cell therapy
cancer
drug manufacturing
Study: Gilead antiviral drug shows promise as a treatment for Ebola Sudan
Stat
Thu, 03/14/24 - 06:25 pm
Gilead Sciences
obeldesivir
Ebola Sudan
antivirals
Gilead tries new triple-target T-cell engagers in $1.5B-plus Merus collab
Fierce Biotech
Wed, 03/6/24 - 11:30 am
Gilead Sciences
Merus
T-cell engager
Gilead Secures $210M from VC to Build Trodelvy’s Clinical Case in NSCLC
BioSpace
Fri, 03/1/24 - 11:48 am
Gilead Sciences
funding
Trodelvy
non-small cell lung cancer
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
PhRMA, navigating turbulence, taps Gilead CEO to helm board of directors
Fierce Pharma
Wed, 02/21/24 - 10:43 pm
PhRMA
lobbying
Daniel O'Day
Gilead Sciences
Gilead Sciences pauses enrollment for cancer treatment in solid tumor trials
Reuters
Thu, 02/15/24 - 07:14 pm
Gilead Sciences
magrolimab
solid tumors
Gilead pays $4.3B for CymaBay, the biotech that never gave up on liver disease med
Fierce Biotech
Mon, 02/12/24 - 11:53 am
Gilead Sciences
CymaBay Therapeutics
M&A
liver disease
seladelpar
primary biliary cholangitis
FDA puts hold on Gilead's blood cancer therapy trials
Reuters
Wed, 02/7/24 - 09:20 pm
Gilead Sciences
FDA
clinical trials
magrolimab
blood cancer
Gilead will not buy Tizona after paying $300M for the right to do so
Fierce Biotech
Wed, 02/7/24 - 11:17 am
Gilead Sciences
Tizona Therapeutics
M&A
oncology
Amgen earnings boosted by Horizon deal, Gilead quarterly revenue drops
Medical Marketing and Media
Tue, 02/6/24 - 11:41 pm
Amgen
Gilead Sciences
earnings
Horizon Therapeutics
M&A
Gilead-backed Kyverna Therapeutics aims for $857.3 mln valuation in upsized IPO
Reuters
Tue, 02/6/24 - 09:17 am
Kyvera Therapeutics
IPOs
Gilead Sciences
autoimmune diseases
Gilead invests $320M in Arcus to increase stake to 33%
Medical Marketing and Media
Wed, 01/31/24 - 10:32 pm
Gilead Sciences
Arcus Biosciences
immuno-oncology
Gilead’s Kite Gets FDA Approval for Faster CAR T Therapy Manufacturing
BioSpace
Wed, 01/31/24 - 11:58 am
Gilead Sciences
Kite Pharma
FDA
drug manufacturing
Yescarta
CAR-T
Gilead stops phase 3 TIGIT trial, doubling down on other studies and pumping $320M into partner Arcus
Fierce Biotech
Tue, 01/30/24 - 10:34 am
Gilead Sciences
Arcus Biosciences
Tigit
lung cancer
clinical trials
Gilead's Tecartus gets revised safety demand amid FDA's push for CAR-T boxed warnings
Fierce Pharma
Wed, 01/24/24 - 10:46 am
Gilead Sciences
Tecartus
CAR-T
FDA
FDA requires 'boxed warning' for CAR-T cancer therapies
Reuters
Mon, 01/22/24 - 10:10 pm
CAR-T
FDA
warnings
Gilead Sciences
JNJ
Novartis
Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff
Fierce Pharma
Mon, 01/22/24 - 11:21 am
Gilead Sciences
antibody-drug conjugate
Trodelvy
lung cancer
clinical trials
Gilead calls off Oceanside manufacturing expansion, uproots biologics development team
Fierce Pharma
Wed, 01/17/24 - 08:45 pm
Gilead Sciences
biologics
California
drug manufacturing
CAR-T hype faces infrastructure reality check
Fierce Pharma
Tue, 01/16/24 - 09:22 am
CAR-T
cell therapy
gene therapy
Gilead Sciences
JNJ
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »